ArticleExperimental hematology & oncology2025
Inhibition of EYA family tyrosine phosphatase activity reveals a therapeutic vulnerability and enhances Menin and DOT1L inhibitor efficacy in KMT2A-rearranged leukemia.
Lola Badmus et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.